DATANG RENEW Announces Asset Impairment Provisions to Reduce 2025 Net Profit by Approximately 193 Million Yuan

Stock News
昨天

DATANG RENEW (01798) has issued an announcement regarding the impairment of certain assets. Adhering to the principle of prudence, the company conducted impairment tests on its assets and those of its subsidiaries in accordance with the Chinese Accounting Standards for Business Enterprises and its internal accounting policies. Based on the test results, the company plans to recognize impairment provisions for assets showing signs of diminished value.

The specific details of the asset impairment provisions are as follows: After assessing the expected recoverable amounts of its receivables, the company identified a recovery risk for certain receivables and plans to recognize an impairment provision of approximately RMB 18.4341 million. Due to operational difficulties at one of its equity-accounted investees, creating a risk of loss on the investment, the company plans to recognize an impairment loss of approximately RMB 497,500 on this long-term equity investment. Furthermore, as certain preliminary-stage projects are no longer viable for development, the company has terminated related preliminary work and plans to recognize an impairment provision of approximately RMB 204 million for the associated preliminary project expenses.

Collectively, these asset impairment provisions are expected to reduce the company's total profit for the year ending December 31, 2025, by approximately RMB 223 million. The net profit attributable to owners of the parent company for the same period is projected to decrease by approximately RMB 193 million.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10